A new study recently published in PLOS Medicine demonstrates that Verigene BC-GP can accurately and quickly detect bloodstream infections that cause sepsis so that treatments can be decided upon in a timely fashion.
The author concludes that “this new test will prevent the misuse and overprescription of antibiotics because patients will be treated almost two days sooner than they would have been using previous diagnosis methods… this new testing technology may favorably alter the global incidence of sepsis, potentially saving thousands of lives.”
The complete article by Anoopa Singh is available at Medical Daily.
